Matt Larew

Stock Analyst at William Blair

(0)
# 5345
Out of 5,441 analysts
17
Total ratings
Success rate
Average return
11 Stocks
Name Action PT Current % Upside Ratings Updated
MXCT MaxCyte
Downgrades: Market Perform
n/a
n/a n/a 2 Aug 7, 2025
MRVI Maravai LifeSciences
Downgrades: Market Perform
n/a
n/a n/a 1 Nov 8, 2024
AMED Amedisys
Downgrades: Market Perform
n/a
n/a n/a 1 Jul 1, 2024
DNA Ginkgo Bioworks Hold...
Downgrades: Underperform
n/a
n/a n/a 3 May 10, 2024
ATR AptarGroup
Upgrades: Outperform
n/a
n/a n/a 1 Apr 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Aug 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Jul 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Sep 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Sep 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Aug 4, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Jun 29, 2021